1140 материалов по теме, собраны автоматически из проверенных источников
Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant immunochemotherapy (ICT) and who underwent less extensive surgery had high disease-free survival and organ preservation rates, according to a study published in Clinical Cancer Research, authored by Kunyu…
New pancreatic cancer treatment gets FDA approval after clinical trials at City of Hope CBS News
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection.
Early Trial Results for Tumor Regression – Featured Research seattlechildrens.org
OSF Cancer institute joins National Research Network, expanding clinical trial opportunities WEEK | 25 News Now
Most patients with localized appendix cancer may be able to safely avoid chemotherapy after surgery, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.
Arizona's clinical trials help accelerate cancer treatment breakthroughs 12News
Most Patients with Appendix Cancer May Avoid Chemotherapy After Surgery, Study Suggests | Newswise newswise.com
Measuring the Human Side of Cancer Research | Newswise newswise.com
Placebos in Cancer Clinical Trials: What Patients Need to Know Cure Today
How advancements in blood cancer research are saving lives wxxinews.org
People with invasive cancer may be more likely to experience ischemic stroke, according to results of a retrospective cohort study. Risk — which varied considerably by cancer type — appeared particularly elevated in the first few months after diagnosis. This establishes “a critical window” for targeted assessment and…
Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82 The ASCO Post
Как современные исследования меняют лечение рака груди smartpress.by
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a possible reason why metastatic medullary thyroid cancer causes abnormal bone growth, pointing to a new opportunity to detect and monitor bone metastases in patients.